← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
CF Industries converted stronger nitrogen markets into rapid growth, a 33% margin and $1.8 billion of free cash flow.
The read at a glance✓ Audited against SEC data
- Growth — Revenue grew 19.3%OK
- Profitability — Net income grew 21.7% to $1.798B from $1.477BOK
- Cash flow — Free cash flow grew 2.8% to $1.802B from $1.753BOK
- Margins — Operating margin expanded 306 bps to 32.47%OK
- Accounting — Exceptional fertilizer cash generationNote
- Insiders — 0 purchases and 29 salesWatch
Business
CF Industries manufactures ammonia, urea and other nitrogen fertilizers and industrial products.
Where the revenue comes from
Fiscal 2025, as CF Industries Holdings, Inc. reports it. History and quarterly detail are in the app.
- Ammonia$2.2B
- UAN$2.2B
- Urea$1.8B
- Other$545.0M
- AN$421.0M
Leadership changes
From CF Industries Holdings, Inc.'s own filings, the day they're filed.
- Andrew T. Scribner · chief financial officer · appointmenteff. 2026-05-26
- Richard A. Hoker · CFO · appointmenteff. 2026-02-15
- W. Anthony Will · chief executive officer · departureeff. 2026-01-04
Latest filings
- 8-K · Company announcement2026-09-03
- 10-Q · Quarterly report2026-08-06
- 8-K · Company announcement2026-08-05
- 8-K · Company announcement2026-08-05
- 10-Q · Quarterly report2026-05-07
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about CF Industries Holdings, Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.